Clinical trial for Diabetic Macular Edema (DME)
Official title Corticosteroid for Diabetic Macular Edema (DME) Study
ClinicalTrials.gov ID: NCT07843849
What this study is testing
What is Intravitreal dexamethasone implant?
An investigational eye implant being studied for diabetic macular edema (DME). It is designed to release dexamethasone slowly into the eye to reduce inflammation.
Also referred to as Dexamethasone.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to see if eye inflammation markers change after steroid injections for diabetic macular swelling.
- Who it's for
- Adults with diabetic macular swelling and diabetic eye disease.
- What's involved
- Participants will receive steroid injections into the eye and have eye fluid samples taken before and after treatment.
- Time commitment
- The study will last about one year, with eye visits and fluid tests scheduled around the injections.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Adult patients age 18 years or older with type II diabetes, with baseline moderate NPDR and DME.
You likely can't join if
- Patients with a history of previous vitrectomy in either eye; prior antivegf intravitreal injection within 3 months
The study team makes the final eligibility decision.
Where it is enrolling
- Nashville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Nashville, Tennessee, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.